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left ventricular ejection fraction (LVEF), valve prosthesis type and
position of valve, chordal preservation surgery, atrial ﬁbrillation
(AF), left atrial (LA) size] as predictor to PHVT and the outcome of
management by thrombolysis. In the current study, we intend to
evaluate whether AF is an independent predictor of PHVT.
Methods:Weprospectively collected data of all patients presenting
to our out-patient, in-patient and emergency room of department
of cardiology. All baseline parameters (demographic characteris-
tics, compliance to OAC, LVEF, valve prosthesis type and position
of valve, AF and LA size) were noted and were subjected to uni-
variate and multivariate analysis to determine their association to
PHVT.
Results: Since June 2013 to June 2015, 33 patients (20 female,
13male) with PHVT were admitted to our department. Baseline
characteristics are shown in Table 1.
Mean age of patients presenting with PHVTwas 39  12 years, with
females accounting for 2/3rd of the all PHVT patients. A total of 36
valves were thrombosed in 33 patients. Mitral valvewas affected in
28 patients and 8 patients had thrombosis of aortic valve. Mean
time duration after valve replacement till presentation with PHVT
was 4 (range 4–240)months. Mean LA diameter at was 44  16 mm.
24 (72%) of patients were in AF and overall the LVEF was almost
normal in all patients. Only 9 (25%) of patients were compliant to
the OAC prescribed.
Overall themost predominant cause of PHVT is non-compliance to
OAC.
Conclusion: Because of the inadequate number of patients with
PHVT, multivariate analysis could not be done to determine the
signiﬁcance of association of risk factors to PHVT. Overall non-
compliance to OAC appears to be the most important cause of
PHVT. AF in association is found in 72% of patients.
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Background: Stroke is a serious complication of atrial ﬁbrillation
(AF) and oral anticoagulants are effective in reducing the risk of
stroke. New oral anticoagulants (NOAC's) are available now as
alternatives.
Aims: (1) To study the clinical proﬁle of patients with AF and
attendant problems, (2) to assess the risk of stroke and bleeding
in patients with non valvar AF (NVAF) and (3) to study the fre-
quency of usage of vitamin K antagonists (VKA) and NOACs and
their attendant problems.
Methods: All consecutively hospitalized patients with AF and
those patients with AF seen in cardiology OPD were included in
this observational prospective registry study. CHA2DS2-VASc and
HASBLED scores were applied in patients with NVAF. Renal func-
tion was assessed by Cockroft–Gault formula.
Results: Of 106 patients, 56 (52.83%) were males and 50 (47.17%)
were females. The mean age was 64.67 years. 31 (29.24%) patients
had valvar AF, and 75 (70.76%) NVAF. 16 (15.09%) patients had
stroke. 51 (48.11%) had hypertension, 23 (21.69%) had diabetes, 21
(19.81%) had coronary artery disease, 5 (4.71%) had cardiomyopa-
thy, 18 (16.9%) were detected to have thyroid dysfunction and 7
(6.6%) chronic kidney disease.
The mean CHA2DS2-VASc score was 3.54, and HASBLED score was
2.11. Of 31 patients of valvar AF, 27 received VKA and 4 patients
took no anticoagulants. Out of 75 patients with NVAF, 17 received
NOAC, 29were onVKA (26 refusedNOACdue to cost constraint and
3 had creatinine clearance <30 ml/min) and 29 on antiplatelets
(CHADS score 1 or less in 5 and 24 unwilling to take anticoagulant).
3 switched to NOAC fromVKA, and 1 opted to switch fromNOAC to
VKA. Of 56 patients who were on VKA, 4 had hemorrhagic stroke. 6
patients died. No siginiﬁcant adverse effects were reported with
NOACs except one patient developed hematuria. VKA were asso-
ciated with increase risk of hemorrhagic stroke.
Conclusion:
1. NVAF was more frequent than valvar AF.
2. Antiplatelets are still being used inappropriately.
3. NOACs are attractive alternatives to VKA, but are expensive.
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The combination of ventricular tachycardia (VT) and severe left
ventricular dysfunction presents a serious challenge in manage-
ment of acute fulminant myocarditis (AFM). We present a case of a
52-year-old male with AFM, who presented with hypotension and
incessant VT not responsive to pharmacological therapy. He
underwent successful catheter ablation.
Introduction:Myocarditis is clinically and pathologically deﬁned as
‘‘inﬂammation of the myocardium’’. Clinical presentations of the
disease range from nonspeciﬁc systemic symptoms (fever, myal-
gias, palpitations, or exertional dyspnea) to fulminant hemody-
namic collapse and sudden death. Furthermore, it has been
identiﬁed as a cause of dilated cardiomyopathy in 9% of cases in
a large prospective series. Endomyocardial biopsy and autopsy
ﬁndings have clearly demonstrated that myocarditis represents
a frequent cause of life-threatening ventricular arrhythmias and
sudden death.
Electroanatomic mapping allows operators to record intracardiac
electrical activation in relation to anatomic location in a cardiac
chamber of interest, even during arrhythmia mapping. Although
use of electrophysiological ablation in AFM has not been docu-
mented widely, in exceptional cases where VT is not responding to
conventional treatment ablation remains a useful alternative.
Case:A 52-year-oldmale known case of hypertension and diabetes
mellitus since last 10 years had a history of traveling in last 15 days
following which he started experiencing fever and breathlessness.
Further, he developed swelling over his feet, abdomen and face for
which he admitted in a private hospital where he was managed
medically. But his condition went on deteriorating and he had
incessant VT for which he was given around 20 DC shock and was
intubation and IABP was inserted. 2D Echo was done which
showed global LV hypokinesia with ejection fraction of 25–30%.
He was diagnosed to be suffering from viral myocarditis and was
Table 1
Baseline characteristics n = 33
Age (mean  SD), years 39  12
Sex (M:F) 20:13
Valve at mitral position 28
Valve at aortic position 8
Time duration since valve replacement
(months, range)
34 (4–240)
LA diameter in mm (mean  SD) 44  16
Patients with AF [n (%)] 24 (72%)
LVEF (%) 58  6%
Compliance to OAC, n (%) 6 (25%)
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